A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices.
AMA J Ethics. 2021; 23(9):E712-720. doi:
10.1001/amajethics.2021.712.
Most women requesting pregnancy termination have already decided to undergo an abortion, but some jurisdictions have implemented strategies to induce doubt and regret.
AMA J Ethics. 2020; 22(9):E792-795. doi:
10.1001/amajethics.2020.792.
Distinguishing between elective and therapeutic abortions undermines the moral agency of patients and disproportionately amplifies moral rather than medical dimensions of the procedure.
AMA J Ethics. 2018; 20(12):E1175-1180. doi:
10.1001/amajethics.2018.1175.
Many pregnant undocumented immigrants are ineligible for public insurance covering prenatal care. National and state policies can either help or hinder patients’ access to health care that is universally recommended by professional guidelines.
AMA J Ethics. 2019; 21(1):E93-99. doi:
10.1001/amajethics.2019.93.
Physicians should provide women considering abortion after Down syndrome screening with unbiased information and not attempt to influence their decision.
AMA J Ethics. 2016; 18(4):359-364. doi:
10.1001/journalofethics.2016.18.4.ecas1-1604.
Labels commonly used in clinical settings, like “elective” or “therapeutic,” influence how we think about the justifiability of abortion. We talk with Professor Katie Watson and Dr Maryl Sackeim about how the language clinicians use to describe abortion can affect patients’ experiences and even cause harm.